pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-1245a |
Genomic Coordinates | chr2: 188978092 - 188978161 |
Description | Homo sapiens miR-1245a stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-1245a | |||||||||||||||||||||
Sequence | 45| AAGUGAUCUAAAGGCCUACAU |65 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
|||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CREBBP | ||||||||||||||||||||
Synonyms | CBP, KAT3A, RSTS, RSTS1 | ||||||||||||||||||||
Description | CREB binding protein | ||||||||||||||||||||
Transcript | NM_001079846 | ||||||||||||||||||||
Other Transcripts | NM_004380 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CREBBP | |||||||||||||||||||||
3'UTR of CREBBP (miRNA target sites are highlighted) |
>CREBBP|NM_001079846|3'UTR 1 CATTGTGAGAGCATCACCTTTTCCCTTTCATGTTCTTGGACCTTTTGTACTGAAAATCCAGGCATCTAGGTTCTTTTTAT 81 TCCTAGATGGAACTGCGACTTCCGAGCCATGGAAGGGTGGATTGATGTTTAAAGAAACAATACAAAGAATATATTTTTTT 161 GTTAAAAACCAGTTGATTTAAATATCTGGTCTCTCTCTTTGGTTTTTTTTTGGCGGGGGGGTGGGGGGGGTTCTTTTTTT 241 TCCGTTTTGTTTTTGTTTGGGGGGAGGGGGGTTTTGTTTGGATTCTTTTTGTCGTCATTGCTGGTGACTCATGCCTTTTT 321 TTAACGGGAAAAACAAGTTCATTATATTCATATTTTTTATTTGTATTTTCAAGACTTTAAACATTTATGTTTAAAAGTAA 401 GAAGAAAAATAATATTCAGAACTGATTCCTGAAATAATGCAAGCTTATAATGTATCCCGATAACTTTGTGATGTTTCGGG 481 AAGATTTTTTTCTATAGTGAACTCTGTGGGCGTCTCCCAGTATTACCCTGGATGATAGGAATTGACTCCGGCGTGCACAC 561 ACGTACACACCCACACACATCTATCTATACATAATGGCTGAAGCCAAACTTGTCTTGCAGATGTAGAAATTGTTGCTTTG 641 TTTCTCTGATAAAACTGGTTTTAGACAAAAAATAGGGATGATCACTCTTAGACCATGCTAATGTTACTAGAGAAGAAGCC 721 TTCTTTTCTTTCTTCTATGTGAAACTTGAAATGAGGAAAAGCAATTCTAGTGTAAATCATGCAAGCGCTCTAATTCCTAT 801 AAATACGAAACTCGAGAAGATTCAATCACTGTATAGAATGGTAAAATACCAACTCATTTCTTATATCATATTGTTAAATA 881 AACTGTGTGCAACAGACAAAAAGGGTGGTCCTTCTTGAATTCATGTACATGGTATTAACACTTAGTGTTCGGGGTTTTTT 961 GTTATGAAAATGCTGTTTTCAACATTGTATTTGGACTATGCATGTGTTTTTTCCCCATTGTATATAAAGTACCGCTTAAA 1041 ATTGATATAAATTACTGAGGTTTTTAACATGTATTCTGTTCTTTAAGATCCCTGTAAGAATGTTTAAGGTTTTTATTTAT 1121 TTATATATATTTTTTGAGTCTGTTCTTTGTAAGACATGGTTCTGGTTGTTCGCTCATAGCGGAGAGGCTGGGGCTGCGGT 1201 TGTGGTTGTGGCGGCGTGGGTGGTGGCTGGGAACTGTGGCCCAGGCTTAGCGGCCGCCCGGAGGCTTTTCTTCCCGGAGA 1281 CTGAGGTGGGCGACTGAGGTGGGCGGCTCAGCGTTGGCCCCACACATTCGAGGCTCACAGGTGATTGTCGCTCACACAGT 1361 TAGGGTCGTCAGTTGGTCTGAAACTGCATTTGGCCCACTCCTCCATCCTCCCTGTCCGTCGTAGCTGCCACCCCCAGAGG 1441 CGGCGCTTCTTCCCGTGTTCAGGCGGCTCCCCCCCCCCGTACACGACTCCCAGAATCTGAGGCAGAGAGTGCTCCAGGCT 1521 CGCGAGGTGCTTTCTGACTTCCCCCCAAATCCTGCCGCTGCCGCGCAGCATGTCCCGTGTGGCGTTTGAGGAAATGCTGA 1601 GGGACAGACACCTTGGAGCACCAGCTCCGGTCCCTGTTACAGTGAGAAAGGTCCCCCACTTCGGGGGATACTTGCACTTA 1681 GCCACATGGTCCTGCCTCCCTTGGAGTCCAGTTCCAGGCTCCCTTACTGAGTGGGTGAGACAAGTTCACAAAAACCGTAA 1761 AACTGAGAGGAGGACCATGGGCAGGGGAGCTGAAGTTCATCCCCTAAGTCTACCACCCCCAGCACCCAGAGAACCCACTT 1841 TATCCCTAGTCCCCCAACAAAGGCTGGTCTAGGTGGGGGTGATGGTAATTTTAGAAATCACGCCCCAAATAGCTTCCGTT 1921 TGGGCCCTTACATTCACAGATAGGTTTTAAATAGCTGAATACTTGGTTTGGGAATCTGAATTCGAGGAACCTTTCTAAGA 2001 AGTTGGAAAGGTCCGATCTAGTTTTAGCACAGAGCTTTGAACCTTGAGTTATAAAATGCAGAATAATTCAAGTAAAAATA 2081 AGACCACCATCTGGCACCCCTGACCAGCCCCCATTCACCCCATCCCAGGAGGGGAAGCACAGGCCGGGCCTCCGGTGGAG 2161 ATTGCTGCCACTGCTCGGCCTGCTGGGTTCTTAACCTCCAGTGTCCTCTTCATCTTTTCCACCCGTAGGGAAACCTTGAG 2241 CCATGTGTTCAAACAAGAAGTGGGGCTAGAGCCCGAGAGCAGCAGCTCTAAGCCCACACTCAGAAAGTGGCGCCCTCCTG 2321 GTTGTGCAGCCTTTTAATGTGGGCAGTGGAGGGGCCTCTGTTTCAGGTTATCCTGGAATTCAAAACGTTATGTACCAACC 2401 TCATCCTCTTTGGAGTCTGCATCCTGTGCAACCGTCTTGGGCAATCCAGATGTCGAAGGATGTGACCGAGAGCATGGTCT 2481 GTGGATGCTAACCCTAAGTTTGTCGTAAGGAAATTTCTGTAAGAAACCTGGAAAGCCCCAACGCTGTGTCTCATGCTGTA 2561 TACTTAAGAGGAGAAGAAAAAGTCCTATATTTGTGATCAAAAAGAGGAAACTTGAAATGTGATGGTGTTTATAATAAAAG 2641 ATGGTAAAACTACTTGGATTCAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000262367.5 | 3UTR | AUCACUCUUAGACCAUGCUAAUGUUACUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
109 hsa-miR-1245a Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT006574 | BRCA2 | BRCA2, DNA repair associated | 2 | 1 | ||||||||
MIRT055432 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 2 | ||||||||
MIRT063879 | RASSF8 | Ras association domain family member 8 | 2 | 6 | ||||||||
MIRT077025 | WIPF2 | WAS/WASL interacting protein family member 2 | 2 | 2 | ||||||||
MIRT095775 | GRPEL2 | GrpE like 2, mitochondrial | 2 | 10 | ||||||||
MIRT099172 | MAP3K4 | mitogen-activated protein kinase kinase kinase 4 | 2 | 2 | ||||||||
MIRT175616 | OCRL | OCRL, inositol polyphosphate-5-phosphatase | 2 | 2 | ||||||||
MIRT456518 | LYPLAL1 | lysophospholipase like 1 | 2 | 2 | ||||||||
MIRT464457 | UGCG | UDP-glucose ceramide glucosyltransferase | 2 | 2 | ||||||||
MIRT465747 | TMPPE | transmembrane protein with metallophosphoesterase domain | 2 | 2 | ||||||||
MIRT468257 | SFXN4 | sideroflexin 4 | 2 | 2 | ||||||||
MIRT469216 | RICTOR | RPTOR independent companion of MTOR complex 2 | 2 | 2 | ||||||||
MIRT472045 | NPAT | nuclear protein, coactivator of histone transcription | 2 | 2 | ||||||||
MIRT481795 | APEX1 | apurinic/apyrimidinic endodeoxyribonuclease 1 | 2 | 2 | ||||||||
MIRT500154 | CREBBP | CREB binding protein | 2 | 2 | ||||||||
MIRT506514 | MSANTD4 | Myb/SANT DNA binding domain containing 4 with coiled-coils | 2 | 4 | ||||||||
MIRT506915 | KBTBD8 | kelch repeat and BTB domain containing 8 | 2 | 6 | ||||||||
MIRT513901 | GRB10 | growth factor receptor bound protein 10 | 2 | 6 | ||||||||
MIRT519128 | ALDH2 | aldehyde dehydrogenase 2 family (mitochondrial) | 2 | 2 | ||||||||
MIRT528121 | FOXH1 | forkhead box H1 | 2 | 2 | ||||||||
MIRT528942 | SFMBT2 | Scm like with four mbt domains 2 | 2 | 2 | ||||||||
MIRT540580 | CEP89 | centrosomal protein 89 | 2 | 2 | ||||||||
MIRT545858 | ZNF264 | zinc finger protein 264 | 2 | 4 | ||||||||
MIRT547147 | PGM3 | phosphoglucomutase 3 | 2 | 2 | ||||||||
MIRT547434 | MED4 | mediator complex subunit 4 | 2 | 2 | ||||||||
MIRT554650 | ROBO1 | roundabout guidance receptor 1 | 2 | 2 | ||||||||
MIRT558524 | CSRNP3 | cysteine and serine rich nuclear protein 3 | 2 | 2 | ||||||||
MIRT559762 | ABHD5 | abhydrolase domain containing 5 | 2 | 2 | ||||||||
MIRT560438 | GOLGA7B | golgin A7 family member B | 2 | 2 | ||||||||
MIRT561974 | LRRC59 | leucine rich repeat containing 59 | 2 | 2 | ||||||||
MIRT562442 | DDIT4 | DNA damage inducible transcript 4 | 2 | 2 | ||||||||
MIRT563489 | ZWINT | ZW10 interacting kinetochore protein | 2 | 2 | ||||||||
MIRT568265 | BMP2K | BMP2 inducible kinase | 2 | 2 | ||||||||
MIRT572522 | KIAA0232 | KIAA0232 | 2 | 2 | ||||||||
MIRT612801 | LSM14A | LSM14A, mRNA processing body assembly factor | 2 | 2 | ||||||||
MIRT621533 | ZNF507 | zinc finger protein 507 | 2 | 2 | ||||||||
MIRT625205 | GSTCD | glutathione S-transferase C-terminal domain containing | 2 | 2 | ||||||||
MIRT625615 | ZNF84 | zinc finger protein 84 | 2 | 2 | ||||||||
MIRT629215 | C12orf66 | chromosome 12 open reading frame 66 | 2 | 2 | ||||||||
MIRT629509 | AS3MT | arsenite methyltransferase | 2 | 2 | ||||||||
MIRT629769 | STK25 | serine/threonine kinase 25 | 2 | 2 | ||||||||
MIRT630908 | GATAD1 | GATA zinc finger domain containing 1 | 2 | 2 | ||||||||
MIRT632508 | RAB13 | RAB13, member RAS oncogene family | 2 | 2 | ||||||||
MIRT636871 | ARSE | arylsulfatase E (chondrodysplasia punctata 1) | 2 | 2 | ||||||||
MIRT637106 | CXorf23 | BCLAF1 and THRAP3 family member 3 | 2 | 2 | ||||||||
MIRT637332 | FAM9B | family with sequence similarity 9 member B | 2 | 2 | ||||||||
MIRT637553 | CHST6 | carbohydrate sulfotransferase 6 | 2 | 2 | ||||||||
MIRT637639 | ZNF431 | zinc finger protein 431 | 2 | 2 | ||||||||
MIRT637836 | CACNG8 | calcium voltage-gated channel auxiliary subunit gamma 8 | 2 | 2 | ||||||||
MIRT638326 | RNF11 | ring finger protein 11 | 2 | 2 | ||||||||
MIRT638393 | RAB11FIP1 | RAB11 family interacting protein 1 | 2 | 2 | ||||||||
MIRT642450 | CLUAP1 | clusterin associated protein 1 | 2 | 2 | ||||||||
MIRT642616 | APOPT1 | apoptogenic 1, mitochondrial | 2 | 2 | ||||||||
MIRT643133 | FAM71F2 | family with sequence similarity 71 member F2 | 2 | 2 | ||||||||
MIRT644324 | NFKBID | NFKB inhibitor delta | 2 | 2 | ||||||||
MIRT645150 | DIS3 | DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease | 2 | 2 | ||||||||
MIRT645673 | ADK | adenosine kinase | 2 | 2 | ||||||||
MIRT646091 | MGST3 | microsomal glutathione S-transferase 3 | 2 | 2 | ||||||||
MIRT646858 | SLC35E4 | solute carrier family 35 member E4 | 2 | 2 | ||||||||
MIRT650153 | ZNF426 | zinc finger protein 426 | 2 | 2 | ||||||||
MIRT652483 | TMEM181 | transmembrane protein 181 | 2 | 2 | ||||||||
MIRT653790 | SIRPA | signal regulatory protein alpha | 2 | 2 | ||||||||
MIRT655526 | PAG1 | phosphoprotein membrane anchor with glycosphingolipid microdomains 1 | 2 | 2 | ||||||||
MIRT657077 | JPH2 | junctophilin 2 | 2 | 2 | ||||||||
MIRT657322 | HOOK3 | hook microtubule tethering protein 3 | 2 | 2 | ||||||||
MIRT662036 | FUT2 | fucosyltransferase 2 | 2 | 2 | ||||||||
MIRT662322 | ADM2 | adrenomedullin 2 | 2 | 2 | ||||||||
MIRT663211 | DARS2 | aspartyl-tRNA synthetase 2, mitochondrial | 2 | 2 | ||||||||
MIRT663559 | CCR6 | C-C motif chemokine receptor 6 | 2 | 2 | ||||||||
MIRT663937 | ZNF554 | zinc finger protein 554 | 2 | 2 | ||||||||
MIRT664689 | EIF2B2 | eukaryotic translation initiation factor 2B subunit beta | 2 | 2 | ||||||||
MIRT664709 | PAICS | phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase | 2 | 2 | ||||||||
MIRT665291 | ZFP14 | ZFP14 zinc finger protein | 2 | 2 | ||||||||
MIRT665572 | TXNL1 | thioredoxin like 1 | 2 | 2 | ||||||||
MIRT667068 | PAOX | polyamine oxidase | 2 | 2 | ||||||||
MIRT667304 | MYO5A | myosin VA | 2 | 2 | ||||||||
MIRT667442 | METTL14 | methyltransferase like 14 | 2 | 2 | ||||||||
MIRT668048 | GTPBP10 | GTP binding protein 10 | 2 | 2 | ||||||||
MIRT669604 | AGO3 | argonaute 3, RISC catalytic component | 2 | 2 | ||||||||
MIRT671088 | ABL2 | ABL proto-oncogene 2, non-receptor tyrosine kinase | 2 | 2 | ||||||||
MIRT674361 | SLC35E3 | solute carrier family 35 member E3 | 2 | 2 | ||||||||
MIRT674962 | ORAI2 | ORAI calcium release-activated calcium modulator 2 | 2 | 2 | ||||||||
MIRT676394 | SEC24D | SEC24 homolog D, COPII coat complex component | 2 | 2 | ||||||||
MIRT676819 | AGMAT | agmatinase | 2 | 2 | ||||||||
MIRT676891 | ENSA | endosulfine alpha | 2 | 2 | ||||||||
MIRT677059 | ZNF34 | zinc finger protein 34 | 2 | 2 | ||||||||
MIRT678424 | ANKRD36 | ankyrin repeat domain 36 | 2 | 2 | ||||||||
MIRT678735 | SRCAP | Snf2 related CREBBP activator protein | 2 | 2 | ||||||||
MIRT678930 | XPOT | exportin for tRNA | 2 | 2 | ||||||||
MIRT678954 | MYADM | myeloid associated differentiation marker | 2 | 2 | ||||||||
MIRT679228 | MAN2A2 | mannosidase alpha class 2A member 2 | 2 | 2 | ||||||||
MIRT679765 | TLR6 | toll like receptor 6 | 2 | 2 | ||||||||
MIRT681992 | HRH4 | histamine receptor H4 | 2 | 2 | ||||||||
MIRT687405 | NSUN4 | NOP2/Sun RNA methyltransferase family member 4 | 2 | 2 | ||||||||
MIRT694570 | RBMXL1 | RNA binding motif protein, X-linked like 1 | 2 | 2 | ||||||||
MIRT698449 | TM4SF1 | transmembrane 4 L six family member 1 | 2 | 2 | ||||||||
MIRT706406 | HAS2 | hyaluronan synthase 2 | 2 | 2 | ||||||||
MIRT706582 | ZNF432 | zinc finger protein 432 | 2 | 2 | ||||||||
MIRT706838 | VHLL | VHL like | 2 | 2 | ||||||||
MIRT706909 | DVL3 | dishevelled segment polarity protein 3 | 2 | 2 | ||||||||
MIRT707052 | TRPV2 | transient receptor potential cation channel subfamily V member 2 | 2 | 2 | ||||||||
MIRT708583 | C11orf54 | chromosome 11 open reading frame 54 | 2 | 2 | ||||||||
MIRT708988 | CABP4 | calcium binding protein 4 | 2 | 2 | ||||||||
MIRT713041 | ADRA2B | adrenoceptor alpha 2B | 2 | 2 | ||||||||
MIRT713731 | SUCO | SUN domain containing ossification factor | 2 | 2 | ||||||||
MIRT714968 | RAB21 | RAB21, member RAS oncogene family | 2 | 2 | ||||||||
MIRT717485 | PDE4DIP | phosphodiesterase 4D interacting protein | 2 | 2 | ||||||||
MIRT722826 | KLK2 | kallikrein related peptidase 2 | 2 | 2 | ||||||||
MIRT723305 | MOGAT1 | monoacylglycerol O-acyltransferase 1 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|